8FQ-32856-04597
2 vaccinations
5 coded responses
24 check-ins
5 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 299 / SC
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Dose 1 — Pfizer-BioNTech
-
2021-01-28
Registered in v-safe
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
-
2021-02-17
Dose 2 — Pfizer-BioNTech
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
-
2021-02-24
Survey response — day 7, dose 2MedDRA: Facial paralysis, Muscular weakness, Office visit — Feeling: GoodFree text: Went to eye doctor. She sent me to (b)(6) hospital to check for cause of my droopy right eye. Was diagnosed as Myasthenia is not covid vaccine related.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-03
Survey response — day 14, dose 2MedDRA: Myasthenia gravis, Office visit — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Confirmed diagnosis of Myasthenia Gravis. · Healthcare visit (other): Neurologist visit 3/3.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-03
Report sent to call center — day 14, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-10
Survey response — day 21, dose 2MedDRA: Myasthenia gravis, Visual impairment — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Continued treatment for Myasthenia Gravis Taking Pyridostigmine BR 60 MG. 1 tablet 3X a day. Started March 5. Improvement of right eye vision has had very littlevimprovement.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
-
2021-03-24
Survey response — day 35, dose 2MedDRA: Diarrhoea, Medical counselling, Pre-existing disease, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Bad case of diarrhea. Cut Myasthenia Gravis med in half to 30 MG 3X a day. It is Pyridostigmine. Dr care was by phone. · Healthcare visit (other): Wife called. Got his instructions throughDr assistant.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-31
- 2021-05-19
- 2021-08-18
- 2021-11-14
-
2022-02-17
Survey response — 12 months, dose 2MedDRA: Myasthenia gravis, Visual impairment — Feeling: GoodFree text: From after second shot still bothered by Myasthenia Gravis. Will possubly keep me from getting booster. Affects vision.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Pfizer-BioNTech | |
| 2 | 2021-02-17 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
1 wait over 3 months for a first call
Free text
Release 4 — day 7, dose 2
Systemic reaction (other): Went to eye doctor. She sent me to (b)(6) hospital to check for cause of my droopy right eye. Was diagnosed as Myasthenia is not covid vaccine related.
redacted (b)(6)
Release 5 — day 14, dose 2
Symptoms: Confirmed diagnosis of Myasthenia Gravis.
Healthcare visit (other): Neurologist visit 3/3.
Release 5 — day 21, dose 2
Symptoms: Continued treatment for Myasthenia Gravis Taking Pyridostigmine BR 60 MG. 1 tablet 3X a day. Started March 5. Improvement of right eye vision has had very littlevimprovement.
Release 6 — day 35, dose 2
Symptoms: Bad case of diarrhea. Cut Myasthenia Gravis med in half to 30 MG 3X a day. It is Pyridostigmine. Dr care was by phone.
Healthcare visit (other): Wife called. Got his instructions throughDr assistant.
Release 11 — 12 months, dose 2
Symptoms: From after second shot still bothered by Myasthenia Gravis. Will possubly keep me from getting booster. Affects vision.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | · | ✓ |
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | ○ | ✓ | ○ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Medical counselling | ✓ | · | ✓ |
| SD | Myasthenia gravis | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Visual impairment | ✓ | ✓ | ✓ |
| SRO | Facial paralysis | ✓ | ✓ | ✓ |
| SRO | Muscular weakness | ✓ | ✓ | ✓ |
| SRO | Office visit | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release